Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Flyer image

Opinion Article - (2022) Volume 14, Issue 9

Synthetic Cause of Receptor Agonists by Cannabinoid Drug Discrimination
Vandrey Maciej*
 
Department of Pharmacology, Medical University of Lublin, Lublin, Poland
 
*Correspondence: Vandrey Maciej, Department of Pharmacology, Medical University of Lublin, Lublin, Poland, Email:

Received: 29-Aug-2022, Manuscript No. JBB-22-18516; Editor assigned: 01-Sep-2022, Pre QC No. JBB-22-18516 (PQ); Reviewed: 15-Sep-2022, QC No. JBB-22-18516; Revised: 22-Sep-2022, Manuscript No. JBB-22-18516 (R); Published: 29-Sep-2022, DOI: 10.35248/0975-0851.22.14.490

About the Study

Cannabis is a cannabinoid drug. Cannabinoids are natural compounds found in the Cannabis sativa plant. Cannabinoids are a class of molecules that interact with cannabinoid receptors in the human body. More than 480 compounds are found in plants, among them only about 66 are known cannabinoids. Cannabinoids are substances derived from the cannabis plant and include both psychoactive and non-psychoactive compounds known as THC and CBD, as well as compounds known as terpenes. Cannabis has proven effective for several conditions, including pain, seizures, multiple sclerosis, sleep apnea, glaucoma, Crohn's disease, and chemotherapy-induced nausea and vomiting. Cannabinoids are divided into the following subclasses Cannabigerol (CBG), Cannabichromene (CBC), Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabidiol (CBDL), and other cannabinoids including Bicyclol, Cannabielsoin (CBE) and Cannabtriol (CBT).

Cannabis can be added to a variety of foods commonly referred to as 'edibles'. It usually takes 1-3 hours to take effect. Impatient or naive users may think they are not taking enough to feel the effects, and if they take more, they may experience uncomfortably strong psychoactive effects. Inconsistent THC levels in edibles can make it difficult for even experienced users to control their consumption. There are two types of cannabis, Sativa and Indica. Sativa cannabis plants have thin leaves, a long flowering cycle, and can usually reach 12 to 25 feet in height. Indica cannabis, by contrast, has a shorter flowering cycle, noticeably broader leaves, and is smaller and shorter in stature, usually not exceeding 6 feet in height. A hybrid exists between two-parent families and can inherit traits from either indica typically containing more CBD and less THC. It relaxes the mind and body, reduces nausea, increases appetite, and increases dopamine release. Indica is especially recommended for nighttime use. Sativa, by contrast, is typically low in CBD and high in THC, is an anxiolytic and antidepressant, and helps treat chronic pain and regulate learning, mood, sleep, anxiety, and appetite. Sativa is the recommended strain for daytime use.

The main difference between the two cannabinoids is that THC has strong psychoactive effects, meaning it gets a person high, while CBD has antipsychotic effects that control or alleviate the high caused by THC. CBD is thought to reduce some of the other negative effects people can experience from THC. Like opioids, cannabinoids exert their effects by interacting with specific receptors in different parts of the central nervous system. Cannabinoids come in many forms, including leaves, flowers (buds), capsules, foods (gummies, brownies, etc.), creams/ lotions, oils, oral sprays, and tinctures. Illegal and synthetic cannabinoids are commonly smoked, e-cigarette, or eaten. Cannabis affects everyone differently. The same person may have different experiences throughout their lives and occasions. Longterm effects depend on how much cannabis you consume, and how often, it is consumed.

Cannabis use can exacerbate the course of bipolar disorder, and people with a predisposition to psychosis (a common symptom of schizophrenia) may be at increased risk of cannabis-induced psychosis. Cannabinoids have a wide range of effects on the brain. The hippocampus affects learning and memory. Recent studies show that CBD and other non-psychoactive cannabinoids are effective in preventing and treating gastrointestinal disorders such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), Crohn's disease, and ulcerative colitis. It can be used for CBD's anti-inflammatory properties the key to symptom relief and prevention. CBD appears to reduce anxiety at all doses tested. Cannabinoids are present in saliva for up to 24 hours and detectable in blood for up to 12 hours. Synthetic cannabinoid products can be toxic. As a result, people who smoke these products may experience a rapid heart rate. Cannabinoids can also be used recreationally. Cannabis has been used as a medicine for thousands of years. Several ancient texts extolled the plant's healing powers. Synthetic cannabinoids differ from the real cannabis plant in that they contain a variety of compounds not found in the same amounts in the natural cannabis plant. Their effects are simulated and not based on natural cannabinoid receptors, which can be dangerous.

Citation: Maciej V (2022) Synthetic Cause of Receptor Agonists by Cannabinoid Drug Discrimination. J Bioequiv Availab. 14:490.

Copyright: © 2022 Maciej V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.